Excellent Response to Lower Dose of 177Lu-PSMA-617 in a Metastatic Castration-Resistant Prostate Cancer Patient With a Transplanted Kidney

被引:5
作者
Norouzi, Ghazal [1 ]
Aghdam, Ramin Akbarian [1 ]
Hashemifard, Hamidreza [2 ]
Pirayesh, Elahe [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Nucl Med, Shohada & Tajrish Med Ctr, Sch Med, Tehran, Iran
[2] Gandi Hosp, Dept Radiat Oncol, Tehran, Iran
关键词
Lu-177-PSMA-617; prostate cancer; radioligand therapy; nephrotoxicity; kidney transplant; LU-177-PSMA-617 RADIOLIGAND THERAPY;
D O I
10.1097/RLU.0000000000002508
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 68-year-old man with metastatic castration-resistant prostate cancer and widespread bone metastases as well as a history of kidney transplant, underwent 5 cycles of Lu-177-prostate-specific membrane antigen 617 therapies in our department. Being more cautious of the radiation burden imposed on the transplanted kidney, a lower average dose of 4 GBq per cycle was administered (instead of the more routine 6.0-7.4 GBq per cycle). However, excellent response was noted and serum creatinine level of 0.8 mg/dL remained stable.
引用
收藏
页码:483 / 484
页数:2
相关论文
共 9 条
[1]   177Lu-Prostate-Specific Membrane Antigen Super Scan and Good Response Even After 1 Cycle of Radioligand Therapy [J].
Aryana, Kamran ;
Moghadam, Soroush Zarehparvar ;
Salek, Roham ;
Divband, Ghasemali .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) :273-275
[2]   177Lu-PSMA Radioligand Therapy for Prostate Cancer [J].
Fendler, Wolfgang P. ;
Rahbar, Kambiz ;
Herrmann, Ken ;
Kratochwil, Clemens ;
Eiber, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (08) :1196-1200
[3]   Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617 [J].
Ferdinandus, Justin ;
Eppard, Elisabeth ;
Gaertner, Florian C. ;
Kuerpig, Stefan ;
Fimmers, Rolf ;
Yordanova, Anna ;
Hauser, Stefan ;
Feldmann, Georg ;
Essler, Markus ;
Ahmadzadehfar, Hojjat .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) :312-319
[4]   Prostate cancer in renal transplant recipients [J].
Kleinclauss, Francois ;
Gigante, Marc ;
Neuzillet, Yann ;
Mouzin, Marc ;
Terrier, Nicolas ;
Salomon, Laurent ;
Iborra, Francois ;
Petit, Jacques ;
Cormier, Luc ;
Lechevallier, Eric .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) :2374-2380
[5]   Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions [J].
Okamoto, Shozo ;
Thieme, Anne ;
Allmann, Jakob ;
D'Alessandria, Calogero ;
Maurer, Tobias ;
Retz, Margitta ;
Tauber, Robert ;
Heck, Matthias M. ;
Wester, Hans-Juergen ;
Tamaki, Nagara ;
Fendler, Wolfgang P. ;
Herrmann, Ken ;
Pfob, Christian H. ;
Scheidhauer, Klemens ;
Schwaiger, Markus ;
Ziegler, Sibylle ;
Eiber, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) :445-450
[6]   German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients [J].
Rahbar, Kambiz ;
Ahmadzadehfar, Hojjat ;
Kratochwil, Clemens ;
Haberkorn, Uwe ;
Schaefers, Michael ;
Essler, Markus ;
Baum, Richard P. ;
Kulkarni, Harshad R. ;
Schmidt, Matthias ;
Drzezga, Alexander ;
Bartenstein, Peter ;
Pfestroff, Andreas ;
Luster, Markus ;
Luetzen, Ulf ;
Marx, Marlies ;
Prasad, Vikas ;
Brenner, Winfried ;
Heinzel, Alexander ;
Mottaghy, Felix M. ;
Ruf, Juri ;
Meyer, Philipp Tobias ;
Heuschkel, Martin ;
Eveslage, Maria ;
Boegemann, Martin ;
Fendler, Wolfgang Peter ;
Krause, Bernd Joachim .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) :85-90
[7]   Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CT [J].
Roll, Wolfgang ;
Bode, Axel ;
Weckesser, Matthias ;
Boegemann, Martin ;
Rahbar, Kambiz .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) :152-153
[8]   Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer [J].
Soydal, Cigdem ;
Ozkan, Elgin ;
Akyurek, Serap ;
Kucuk, Nuriye Ozlem .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) :159-160
[9]   The impact of repeated cycles of radioligand therapy using [177Lu] Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer [J].
Yordanova, Anna ;
Becker, Anja ;
Eppard, Elisabeth ;
Kuerpig, Stefan ;
Fisang, Christian ;
Feldmann, Georg ;
Essler, Markus ;
Ahmadzadehfar, Hojjat .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) :1473-1479